Literature DB >> 3499049

Morphological evidence of vestibular pathology in long-term experimental diabetes mellitus. II. Connective tissue and neuroepithelial pathology.

S F Myers1, M D Ross.   

Abstract

The influence of long-term experimental diabetes on the saccule and utricle was investigated with light and electron microscopy. Pathological changes involving the connective tissue cells of the subneuroepithelial connective tissue suggest that these cells may play a potentially important role in diabetic pathology of the inner ear. In diabetic animals there was an increased incidence of secondary lysosomes within the connective tissue cells as well as an accumulation of intracellular lipid droplets that increased with the level of hyperglycemia. Five animals with relatively more severe diabetes also had an extensive accumulation of extracellular matrix. Two of these rats with longer diabetes duration had a small number of degenerating type I hair cells scattered through the saccular neuroepithelium, possibly due to chronic stresses from impaired diffusion of oxygen, nutrients and waste material through the dense extracellular matrix. Utricles of these same animals did not have any degenerating hair cells.

Entities:  

Mesh:

Year:  1987        PMID: 3499049     DOI: 10.3109/00016488709109045

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  12 in total

1.  Vascular and Neuroepithelial Histopathology of the Saccule in Humans With Diabetes Mellitus.

Authors:  Pelin Kocdor; Serdar Kaya; Mehmet Erdil; Sebahattin Cureoglu; Michael M Paparella; Meredith E Adams
Journal:  Otol Neurotol       Date:  2016-06       Impact factor: 2.311

Review 2.  Diabetes and Auditory-Vestibular Pathology.

Authors:  Saravanan Elangovan; Christopher Spankovich
Journal:  Semin Hear       Date:  2019-10-09

Review 3.  Diabetes and the Vestibular System.

Authors:  Erin G Piker; Daniel J Romero
Journal:  Semin Hear       Date:  2019-10-09

4.  Dizziness and Loss of Balance in Individuals With Diabetes: Relative Contribution of Vestibular Versus Somatosensory Dysfunction.

Authors:  Megan Walley; Elizabeth Anderson; Mary Walch Pippen; Gerry Maitland
Journal:  Clin Diabetes       Date:  2014-04

5.  Retrospective data suggests that the higher prevalence of benign paroxysmal positional vertigo in individuals with type 2 diabetes is mediated by hypertension.

Authors:  Linda J D'Silva; Hinrich Staecker; James Lin; Kevin J Sykes; Milind A Phadnis; Tamara M McMahon; Dan Connolly; Carla H Sabus; Susan L Whitney; Patricia M Kluding
Journal:  J Vestib Res       Date:  2016       Impact factor: 2.435

6.  Otolith Dysfunction in Persons With Both Diabetes and Benign Paroxysmal Positional Vertigo.

Authors:  Linda J DʼSilva; Hinrich Staecker; James Lin; Christy Maddux; John Ferraro; Hongying Dai; Patricia M Kluding
Journal:  Otol Neurotol       Date:  2017-03       Impact factor: 2.311

7.  Postural sway in individuals with type 2 diabetes and concurrent benign paroxysmal positional vertigo.

Authors:  Linda J D'Silva; Patricia M Kluding; Susan L Whitney; Hongying Dai; Marcio Santos
Journal:  Int J Neurosci       Date:  2017-04-25       Impact factor: 2.292

8.  The impact of diabetes on mobility, balance, and recovery after repositioning maneuvers in individuals with benign paroxysmal positional vertigo.

Authors:  Linda J D'Silva; Susan L Whitney; Marcio Santos; Hongying Dai; Patricia M Kluding
Journal:  J Diabetes Complications       Date:  2017-03-22       Impact factor: 2.852

Review 9.  Impact of Diabetic Complications on Balance and Falls: Contribution of the Vestibular System.

Authors:  Linda J D'Silva; James Lin; Hinrich Staecker; Susan L Whitney; Patricia M Kluding
Journal:  Phys Ther       Date:  2015-08-06

10.  Assessment of vestibular-evoked myogenic potentials and video head impulse test in type 2 diabetes mellitus patients with or without polyneuropathy.

Authors:  Mehmet Kalkan; Ali Bayram; Ferhat Gökay; Hasan Selçuk Cura; Cemil Mutlu
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-01-13       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.